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Abstract
Objetive: The study explored the effects of Plasmodium 
vivax infection on the balance of pro- versus anti- 
inflammatory cytokines and chemokines and their 
relationship with some clinical and epidemiology 
outcomes. 
Methods: Thirty-five pregnant women were recruited. 
Of these, 15 subjects had malaria at delivery (GM+), 
and 20 had no exposition to infection throughout the 
pregnancy (GM-) and at delivery. Epidemiological and 
clinical data were recorded after reviewing the clinical 
records. At delivery, whole blood from the mother as well 
as placental tissue was collected. Diagnosis of infection 
was performed by thick smear and a polymerase chain 
reaction (PCR). Expression of pro-inflammatory and 
anti-inflammatory cytokines and chemokines was 
measured by a real time PCR.
Results: The clinical and epidemiological variables 
explored were similar in both groups, with the exception 
of gestational age. When comparing the GM+ group with 
the GM- group, it is clear that although the differences 
generally are not significant, pro- inflammatory 
cytokines are elevated in both maternal blood and 
placental; anti-inflammatory ones are elevated in the 
mother and reduced in the placenta, and the chemokines 
are reduced in both compartments, except for MCP-1 
which is elevated in all. 
Conclusion: The results appear to be strongly affected 
by the small number of women with GM by P. vivax at 
childbirth. Additional studies are needed with larger 
groups in this and other regions of the country.
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Resumen
Objetivo: En este estudio se determinó el efecto de 
la infección por Plasmodium vivax en el balance de 
citoquinas pro-inflamatorias/anti-inflamatorias y 
quemoquinas  y su relación con algunas variables 
epidemiológicas y clínicas. 
Métodos: Se reclutaron 35 gestantes, 15 con malaria 
en el momento del parto (GM+) y 20 sin malaria en 
ningún momento de la gestación (GM-) Los datos 
epidemiológicos y clínicos fueron colectados a partir 
de la historia clínica. En el momento del parto fueron 
tomadas muestras de sangre periférica materna y tejido 
placentario. El diagnóstico fue realizado mediante gota 
gruesa y reaccion en cadena de la polimerasa (PCR). 
La expresión de citoquinas  pro-inflamatorias/anti-
inflamatorias  y quimioquinas, fueron medidas por 
PCR en tiempo real. La expresión de citoquinas pro-
inflamatorias/anti-inflamatorias y quemoquinas, fueron 
medidas por PCR en tiempo real. 
Resultados: En las variables epidemiológicas y 
clínicas, los datos fueron similares en ambos grupos. 
Al comparar el grupo GM+ con el grupo GM-, resulta 
claro que, aunque las diferencias, en general, no son 
significativas, las citoquinas proinflamatorias están 
elevadas tanto en sangre materna como placentaria, las 
antiinflamatorias están elevadas en la madre y reducidas 
en la placenta, y las quimioquinas están reducidas en 
ambos compartimentos, excepto la MCP-1 que está 
elevada en ambos. Conclusión. Los resultados parecen 
estar fuertemente afectados por la cantidad pequeña de 
mujeres con MG por P. vivax en el parto. Es necesario 
adelantar estudios adicionales con más mujeres tanto en 
esta región como en otros lugares.
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Introduction
Pregnancy involves a greater risk of malaria1. The prevalence and 
severity of gestational malaria (GM) that occurs during pregnancy 
has been studied in Africa, Latin America, Oceania and Asia2. 
What is known about GM and placental malaria (PM) relates to 
Plasmodium falciparum and very little is known about the role of P. 
vivax3. Gestational malaria patients usually present with anemia4. 
A review of seven Latin American studies on GM confirms the 
clinical effects of the infection with P. falciparum as the main 
causing species5. 
During a normal pregnancy the immune response undergoes 
specific changes to allow successful implanting and development 
of the fetus. Therefore, a Th2 profile is observed in successful 
pregnancies, while presence of a Th1 cytokine (pro- inflammatory) 
profile results in spontaneous abortion due to direct cytotoxic 
effects on the trophoblast. Plasmodium infection in the mother 
changes the protective cytokines balance and increases the Th1 
responses leading to complications such as anemia, abortion, 
stillbirth, low birth weight, among other. 
The normal anti-inflammatory status observed in the uninfected 
placenta is mediated by the increased production of cytokines, such 
as interleukin (IL)-10, and transforming growth factor β (TGFβ) 
which probably suppress the immune response mediated by cells. 
During GM-PM, this type of response is required to control 
symptoms, while the parasite is cleared by other mechanisms 6.
The most studied cytokines in the physiopathology of  P.  falciparum 
GM are tumor necrosis factor (TNF), gamma interferon (IFNγ) 
and IL- 10, but other cytokines and chemokines have also been 
explored7. Many cytokines changes during GM-PM might be 
involved in the pathogenesis of gestational malaria resulting in 
low birth weight, intrauterine growth restriction, and preterm 
delivery.
During placental infection, increased production of TNF and 
IFNγ results in injury of the villous trophoblast8. Furthermore, 
macrophage inflammatory protein 1-beta (MIP-1β), TNF and 
IL-8 have been associated with low birth weight and intrauterine 
growth restriction; and Interleukin 1β, IL-6, IL-8 and TNF have all 
been involved in pre-term delivery9,10.  
Accumulation of inflammatory cells, particularly macrophages 
and monocytes, in    the    inter-villous space, results after increased 
MIP-1β. Consequently, both the trophoblastic morphology 
and  placental cytokine production are affected 11. About 25% of 
women with GM have placental monocyte infiltrates at the time of 
delivery and this has been identified as a key factor and predictor of 
low birth weight. It has been suggested that infiltrating monocytes 
represent a significant source of pro-inflammatory cytokines in 
the infected placenta12.
Currently, no reports have been made on the immune balance 
during GM-PM by P. vivax, a species highly endemic in Asia and 
America. The aim of this research was to describe the expression 
profile of the pro-inflammatory cytokines TNF, IFNγ, IL-1β, 
the anti-inflammatory cytokines IL-10, IL-6, TGF-β and the 
chemokines IL-8 (CXCL8), MIP-1 β (CCL4) and MCP-1 (CCL2), 
in pregnant women and placentas infected with P. vivax at the 
time of delivery as well as to describe the association with clinical 
and epidemiological characteristics.
Materials and Methods 
Study site
The study was carried out in north-west Colombia in the locality 
of Puerto Libertador (Cordoba department). Between Antioquia 
and Cordoba departments lays the malaria endemic region known 
as Uraba-Altos Sinu/San Jorge-Bajo Cauca, which has an estimated 
area of 43,506 km2 and a malaria at-risk population of 2.5 million 
distributed in 35 municipalities. 
This large region generates over 60% of malarial cases in Colombia: 
18% in Córdoba and 42% in Antioquia. P. vivax predominates 
over P. falciparum malaria in approximately a 2:1 ratio13. In 2006-
2007, Antioquia and Córdoba contributed, on average, 61,458 
cases of malaria, or 60.2% of the total for Colombia. Those two 
departments during the same years contributed 72.1% of the cases 
of P. vivax, 34.4% of the cases of P. falcpiarum, and 45.7% of the 
cases by both especies14.
Subjects for the current study were recruited at the local hospital 
and the antenatal clinic of “CAMU Divino Niño”, in Puerto 
Libertador.
Study type, design and sample size
Volunteers were enrolled as part of a descriptive, prospective 
and transversal study, between June 2010 and June 2012. The 
sample size was defined by convenience and the lengthy period 
of recruitment was the result of severe and prolonged political 
turmoil in the region, which also jeopardized a random inclusion 
of subjects. Therefore, recruitment took place in a sequential 
fashion until the sample size for the study was reached.
Subjects were grouped as follows: a) parturient women with P. 
vivax GM at delivery (GM+); b) healthy pregnant women without 
GM during pregnancy and at childbirth (GM-). Recruitment took 
place regardless on the presence clinical signs of malaria infection 
at the time of diagnosis.
Thirty-five pregnant participants were enrolled: 15 with GM at 
delivery (GM+), and 20 without GM at the antenatal clinic or at 
delivery (GM-).
Criteria for inclusion and exclusion
Inclusion criteria were>1 year residency in the study region, 
general good health and no history of serious disease, signature of 
the voluntary consent form, hospital delivery and attendance to at 
least three antenatal check-ups. Exclusion criteria were withdrawal 
of the voluntary consent and the finding of a PCR positive for P. 
falciparum infection.
Collection of clinical data
Clinical data were collected after review of the antenatal clinical 
records and delivery charts. Information on mother´s age, weeks 
of gestation, parity, mother´s hemoglobin and newborn weight, 
was recorded.
Sample collection and preparation
Whole blood samples from mother´s peripheral blood and 
placenta were obtained at delivery rooms in the local hospitals of 
Puerto Libertador. The mother`s sample was obtained by finger 
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prick and placental blood was obtained from the lake formed 
following a wash with saline (0.9%) and removal of a 3x3x3 cm 
section in the area of the cord’s insertion on the maternal side of 
the organ. These samples were used to perform thick and thin 
smear examination and PCR as detailed below. In addition, 4ml of 
maternal peripheral blood were collected and immediately stored 
in liquid nitrogen, this and a RNA later® preserved tissue fragment 
obtained from the placenta, were processed for expression of 
cytokines and chemokines.
Diagnosis of Plasmodium infection
The presence of Plasmodium vivax was confirmed in maternal 
and placental blood by thick smear and a nested polymerase 
chain reaction (PCR) according to standard published methods15, 
16. Diagnosis by microscopy was carried out in the field site 
by a trained technician with certified experience in malaria 
diagnosis. Parasitaemia was calculated after observation of fields 
corresponding to 200 leukocytes and a constant of 8,000 leucocytes/
μL. A sample was considered negative after observation of 500 
high power fields. Diagnosis of infection by PCR was performed 
to whole blood samples collected onto Whatman 3MM filter 
paper, from which DNA was extracted using Chelex100® (Sigma™). 
Amplification was carried out using a nested PCR assay to detect 
the 18 s rRNA gene of  P. vivax, according to previously published 
procedures16. The positive reaction control consisted of DNA from 
a well characterized field isolate of P. vivax. Amplification products 
were resolved in a 2% agarose gel using ethidium bromide and 
visualized under UV light. Samples were processed once as long 
as controls were confirmed to operate in optimal conditions, 
otherwise, the assay was repeated until successful performance of 
controls.
For the GM+ group, at least one positive test was required for 
allocation and all tests were required negative for the GMC- group.
Term definitions
The following definitions were applied: A) Low birth weight: 
<2.500 grams. B) Preterm delivery: a pregnancy concluded before 
37 weeks. F) Maternal anaemia: haemoglobin <11 g/dL, G) Full 
term pregnancy: >38 weeks. H) Gestational or pregnancy malaria: 
plasmodial infection diagnosed in a pregnant woman after 
examination of maternal peripheral blood. I) Placental malaria: 
plasmodial infection diagnosed in placenta after examination of 
placental blood.
Cytokines and chemokines expression analysis
Relative quantitation for expression analysis was performed 
using a reverse-transcription real time PCR assay (RT-PCR). 
Total RNA was extracted using QIAamp RNA Blood Mini® 
(QIAGEN) and cDNA was synthesized using First Strand cDNA 
Synthesis® (Fermentas). The quality of the cDNA was confirmed 
by using a conventional PCR for the glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) gene. The reaction was set up in an 
Applied Biosystems Step One Plus system using TaqMan®. Results 
were read at 530 nm. the following genes were analyzed for 
expression: TNF, IFNγ, IL-1β , IL-10, IL-6, TGF-β, IL-8, MIP-1 
and MCP-1 . The efficiency of the PCR reactions was determined 
based on mRNA extracted from a stimulated BeWo cell culture 
or peripheral mononuclear cells from a donor. cDNA was serially 
diluted and expression of β-actin was used to normalize the 
assays using the delta delta CT method (ΔΔCt). The reaction 
was performed in a final volume of 10 uL containing 1 uL DNA, 
5ul TaqMan® master mix (Applied Biosystems), and 0.5 uL of 
20X TaqMan assay mix (primers and probes for each cytokine/
chemokine). All primers were supplied by Applied Biosystems. 
Reactions were performed at  Laboratory of Tropical Diseases of 
the University of New Mexico, USA.
Statistical analyses
Data were analyzed using SPSS 10.0 (SPSS IBM, Armonk, NY). 
Proportions and medians were obtained. Significance was 
established at p<0.05%. The analysis included comparisons with 
using Mann-Whitney U test. Bivariate linear correlations were 
analyzed using Spearman´s rho coefficient.
Ethical issues
The study protocol was reviewed and approved by Ethics 
Committee of Instituto de Investigaciones Medicas, Universidad 
de Antioquia (acta 012: project Colciencias code 111549326134, 
contract 611 de 2009). Volunteers were recruited in accordance 
with national guidelines (Resolution No. 008430 of October 
4, 1993, Republic of Colombia, Ministry of Health), as well 
as international guidelines (Declaration of Helsinki and its 
amendments, World Medical Association (WMA), Edinburgh, 
Scotland, October 2000). Subjects were assigned a code which was 
known only by the researchers.   
Results
Characteristics of the population studied.
A total 35 pregnant women were included in the study, 15 were 
allocated to the GM+ group and 20 to the GM-. . No significant 
differences were observed in the clinical and epidemiological 
variables between the two groups (see Table 1). In both groups, 
there was a significant linear correlation between age and parity 
(rho = 0.868, p = 0.000) and parity and birth weight (rho = 0.628, 
p = 0.000). Pre-term delivery was observed in the GM+ group and 
absent in the GM- group.
Expression of pro-inflamatory/anti-inflamatory cytokines and 
chemokines in placental tissue and maternal peripheral blood.
When comparing the expression of pro-inflammatory and anti-
inflammatory cytokines in placental tissue in the GM+ and GM- 
groups, an increase in the levels of pro-inflammatory cytokines 
(TNF, IFNg and IL1β) was observed in the former. Significance 
in this finding was confirmed for TNF. Regarding the anti-
inflammatory cytokines, these were lower in the GM+ group versus 
the GM- group; however, no significance could be confirmed in 
this result. Similarly, the chemokine MCP-1 was observed high in 
the GM+, but no significant difference was confirmed (Table 2).
In maternal blood, all changes were not statistically significant. 
However, pro-inflammatory cytokines (TNF, IFNg and IL-1β) 
were higher in the GM+ group with respect to the GM- group. 
In addition, all anti-inflammatory cytokines, but TGF-β, were 
increased in the GM+ group when compared to GM-. As for the 
chemokines, IL-8 and MIP-1 were lower, and MCP-1 higher, in 
the GM+ group when compared to GM-.
Discussion
This reports for the first time on the status of cytokines and 
chemokines in women with GM in a P. vivax endemic region 
of America. The technique used to measure the expression of 
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immune mediators is precise and sensitive. Volunteers were 
selected from the general population, particularly those regularly 
attending the hospital facilities in Puerto Libertador. Therefore, 
the study represents the typical population which seeks health 
services in the region.
An obvious limitation in this work is the reduced number of 
women with GM, which is the result of the current socio-political 
instability in the area. Despite the small sample size, the results 
obtained are consistent and suggest a clear trend. 
The study contributes to outline the epidemiology of malarial 
infection during pregnancy in a highly endemic region of the 
country, since it includes subjects whose peripheral and placental 
blood was monitored for P. vivax infection using standard 
microscopy and contributes with the evidence, so far gathered, on 
the deleterious effects of this species 17.
Other authors have reported on the particular predisposition to 
acquire malaria, regardless of the species, according to mother´s 
age, parity and gestational age 18. In the current study, women in 
the GM+ group were younger, with less parity and fewer weeks of 
pregnancy than those in the GM- group.
Others have also reported on P. vivax as responsible of low birth 
weight, maternal anemia and preterm delivery17.  In this study, no 
significant differences were observed on mother´s haemoglobin 
levels or the newborn´s weight. However, children born from 
mothers with GM+ had a mean 215g less weight. In addition, 
preterm delivery occurred in high proportion (18%) in the 
same group. Preterm delivery is a recognized cause of neonatal 
mortality 9, 19.
Pro-inflammatory and anti-inflammatory cytokines and 
chemokines were found altered during GM by P. falciparum and 
this was associated with abortion, stillbirth, preterm delivery, 
intrauterine growth restriction, low birth weight and maternal 
anemia4, 20. However, for P. vivax there is no report on this matter. 
We found an increased expression of all pro-inflammatory 
cytokines studied, both in maternal peripheral blood and in 
placental tissue. Although differences between the groups were 
not significant, the probability values  observed strongly suggest 
that the sample size might have influenced this outcome. Similar 
to the findings herein reported, studies with P. falciparum GM also 
showed increased expression of TNF and IL1β but not IFNγ 21, 22. 
In other reports on P. falciparum GM, increased TNF has been 
associated with fetal growth restriction, spontaneous abortion 
and maternal anemia 22, 23. Likewise, the increase in IL-10 has 
been associated with preterm delivery and increased IFNγ with 
spontaneous abortion.
The beta chemokine MCP-1 has also been reported to increase in 
GM and PM by P. falciparum 24, 25 and it has been associated with 
immune cell recruitment in the placenta, specifically monocyte. 
This chemokine might also be involved in mononuclear 
recruitment in P. vivax infected placentas. Moreover, a rise on IL-8 
has been reported in placentas with active P. falciparum infection 
10, 26.  In the current study, monocytes-macrophages infiltrates 
(data not shown) were observed in infected placentas and the 
concomitant finding of high IL-8 might explain this observation. 
Alternatively, other have implicated hemozoin or parasite´s 
persistence in the immune alterations observed in the placenta 
during malaria infection 27.
In summary, in women with GM at delivery pro-inflammatory 
cytokines tend to be elevated both in maternal blood and placental 
tissue, anti-inflammatory cytokines were high in the mother and 
low in the placenta and the chemokines were reduced in both 
compartments, but MCP-1 which was observed high in placenta 
and mother. The results seemed to be strongly affected by the 
relative small number of women with GM by P. vivax at the time 
of delivery. To consolidate these findings it is necessary to carry 
out additional studies with more women both in this region and 
elsewhere in the country.
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